Can induction of delivery be performed in a case of placenta previa (placenta previa) with fetal demise at 15 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Inducing delivery after fetal demise in a placenta previa situation at 15 weeks is not recommended due to significant risks, including hemorrhage, and requires immediate in-person evaluation by an obstetrician. The management of such a complex medical scenario depends on multiple factors, including the degree of previa, maternal stability, and hospital resources 1. Key considerations include:

  • The risk of hemorrhage associated with placenta previa, which can be life-threatening and requires close monitoring and intervention by specialists.
  • The need for hospitalization to assess the situation thoroughly and determine the safest approach for delivery, whether medical induction, surgical evacuation, or other procedures.
  • The importance of specialized medical expertise in managing this condition, which cannot be provided through a remote platform. Given the potential complications and the need for immediate, specialized care, hospitalization for close monitoring and intervention by obstetric specialists is the recommended course of action. This approach allows for a thorough assessment, appropriate imaging, and determination of the safest method for delivery, prioritizing the reduction of morbidity, mortality, and improvement of quality of life for the patient 1.

From the Research

Induction of Delivery in Placenta Previa with Fetal Demise

  • In cases of placenta previa with fetal demise, the management strategy may involve expectant management or induction of delivery, depending on the gestational age and other factors 2, 3.
  • A study published in 2012 reported a case of fetal death at 23 weeks' gestation with placenta previa, where labor was induced with gemeprost vaginal pessary after 3 weeks of expectant management, resulting in vaginal delivery with significant blood loss 2.
  • Another study from 2017 suggested that about 4 weeks of expectant management may be considered to induce fetal/placental atrophy and decrease uterine blood flow, facilitating vaginal delivery in cases of midtrimester fetal death with placenta previa 3.
  • The use of buccal misoprostol for induction of labor in cases of fetal demise at 14-28 weeks of pregnancy has been studied, with a 200 mcg dose shown to be more effective than a 100 mcg dose in expelling the fetus and placenta within 48 hours 4.
  • In general, the optimal management strategy for placenta previa with fetal demise depends on various factors, including gestational age, maternal health, and the presence of associated conditions like placenta accreta or vasa previa 5, 6.

Considerations for Induction of Delivery

  • The decision to induce delivery in cases of placenta previa with fetal demise should be made on a case-by-case basis, taking into account the individual patient's circumstances and the potential risks and benefits of different management strategies 2, 3.
  • The use of medical induction agents like misoprostol may be considered, but the dosage and administration regimen should be carefully selected based on the patient's specific needs and the available evidence 4.
  • Close monitoring of the patient's condition and the fetal/placental status is essential during the management of placenta previa with fetal demise, regardless of the chosen strategy 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of fetal death with placenta previa.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2012

Research

Placenta Previa.

Clinical obstetrics and gynecology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.